key: cord-0683527-60yrxeie
authors: Jiao, Li; Li, Haiyan; Xu, Jingwen; Yang, Mengli; Ma, Chunxia; Li, Jingmei; Zhao, Siwen; Wang, Haixuan; Yang, Yun; Yu, Wenhai; Wang, Junbin; Yang, Jing; Long, Haiting; Gao, Jiahong; Ding, Kaiyun; Wu, Daoju; Kuang, Dexuan; Zhao, Yuan; Liu, Jiansheng; Lu, Shuaiyao; Liu, Hongqi; Peng, Xiaozhong
title: The gastrointestinal tract is an alternative route for SARS-CoV-2 infection in a nonhuman primate model
date: 2020-12-09
journal: Gastroenterology
DOI: 10.1053/j.gastro.2020.12.001
sha: b04f9a10d3ec3a0eab2cbe3d4490a4ab0db31a3d
doc_id: 683527
cord_uid: 60yrxeie

Background and Aims Gastrointestinal (GI) manifestations have been increasingly reported in Coronavirus Disease 2019 (COVID-19) patients. However, the roles of the GI tract in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection are not fully understood. We investigated how the GI tract is involved in SARS-CoV-2 infection to elucidate the pathogenesis of COVID-19. Methods Our previously established nonhuman primate (NHP) model of COVID-19 was modified in this study to test our hypothesis. Rhesus monkeys were infected with an intragastric or intranasal challenge with SARS-CoV-2. Clinical signs were recorded after infection. Viral genomic RNA was quantified by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Host responses to SARS-CoV-2 infection were evaluated by examining inflammatory cytokines, macrophages, histopathology and mucin barrier integrity. Results Intranasal inoculation with SARS-CoV-2 led to infections and pathological changes not only in respiratory tissues but also in digestive tissues. Expectedly, intragastric inoculation with SARS-CoV-2 resulted in the productive infection of digestive tissues and inflammation in both the lung and digestive tissues. Inflammatory cytokines were induced by both types of inoculation with SARS-CoV-2, consistent with the increased expression of CD68. Immunohistochemistry and alcian blue/periodic acid-Schiff (AB-PAS) staining showed decreased Ki67, increased cleaved caspase 3 and decreased numbers of mucin-containing goblet cells, suggesting that the inflammation induced by these two types of inoculation with SARS-CoV-2 impaired the GI barrier and caused severe infections. Conclusions Both intranasal and intragastric inoculation with SARS-CoV-2 caused pneumonia and GI dysfunction in our rhesus monkey model. Inflammatory cytokines are possible connections for the pathogenesis of SARS-CoV-2 between the respiratory and digestive systems.

Coronavirus disease 2019 , caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), was first reported in December 2019 and has spread globally. 1, 2 Clinical syndromes caused by SARS-CoV-2 infection include acute respiratory distress, severe lung injury, multiple organ failure and even death. 2, 3 Although respiratory symptoms are predominant among clinical syndromes of COVID-19, 20-50% of COVID-19 patients suffer gastrointestinal (GI) manifestations such as abdominal pain, vomiting, nausea and diarrhea. [4] [5] [6] Patients in the intensive care unit have a higher frequency of abdominal pain than patients in the general care unit. 7 The genome of SARS-CoV-2 is approximately 80% identical to that of SARS-CoV, 4 but the GI symptoms of SARS-CoV-2 are more common and severe than those of SARS-CoV and MERS-CoV. 8, 9 Moreover, SARS-CoV-2 RNA has been detected in patient stool [10] [11] [12] and rectal swabs, even after nasal and throat swabs became negative. 8, 12, 13 7 respiratory tract is the key route of transmission. 15 However, both of these proteins are also highly expressed in the digestive system, including in intestinal epithelial cells (IECs) and cholangiocytes. 21 In fact, an increasing number of reports have demonstrated that SARS-CoV-2 productively replicates in human and bat small intestinal enteroids, 14, 22, 23 Here, using a single route of viral challenge in a nonhuman primate (NHP) model of COVID-19, we sought to elucidate how the GI tract is involved in SARS-CoV-2 infection and causes COVID-19. We showed direct evidences for the first time that intranasal inoculation with SARS-CoV-2 caused pneumonia and GI manifestations on the basis of our established rhesus monkey model. Notably, intragastric challenge with SARS-CoV-2 also led to respiratory and digestive dysfunction. These results indicate that the GI tract plays a central role in SARS-CoV-2 pathogenesis. Center. All animals were housed with 1 animal per negative pressure cage in a controlled environment (12-hour daylight cycle and lights off at 8 PM) with free access to food and water.

SARS-CoV-2 was obtained from the Center of Disease Control of Guangdong Province, China.

Viruses were amplified in Vero E6 cells, purified and concentrated with an ultrafilter system with a 300-kDa module (Millipore US). SARS-CoV-2 was confirmed via reverse transcription polymerase chain reaction (RT-PCR), sequencing and transmission electronic microscopy, titrated via a plaque assay (10 7 plaque-forming units (pfu)/ml).

Animal information is detailed in supplementary table 1. Eleven rhesus monkeys were used for two infection experiments in this study. Animals were randomly divided into three groups: PBS represented the day of necropsy post viral inoculation. To reduce the number of experimental J o u r n a l P r e -p r o o f animals, PBS treatment was used as a shared control for both intragastric and intranasal inoculation groups. Rhesus monkeys were intragastrically or intranasally challenged with 1 ml of 1x10 7 pfu SARS-CoV-2, or with PBS via an intragastric or intranasal route. We performed a gavage for intragastric inoculation. Briefly, the animals were anesthetized and lie supine on the operating table. About 20cm length of the silicone rubber gastric tube (3.3mm-fr10) was slowly inserted into the esophagus. A syringe at the end of the gastric tube was drawn back to test whether the tube reached the stomach. If no air was drawn out, the gastric tube had reached the stomach via the esophagus. At this time, 10 7 pfu SARS-CoV-2 in another syringe was pushed into the stomach through the gastric tube, and then at least 20ml of air in another syringe was pushed into the tube to ensure that all SARS-CoV-2 reached the stomach. For the intranasal route, animals were challenged with 500 µl of SARS-CoV-2 (10 7 pfu/ml) for each nostril. As outlined in Figure 1A and 3A, clinical signs (supplementary table 2), weight and rectal temperature were recorded after virus inoculation. At the same time, we collected nasal, throat, and anal swabs and feces for further analysis. At the indicated time points, animal from each group was anesthetized with ketamine, and chest radiographs were recorded, followed by euthanasia and necropsy. At each time point, monkeys with severe chest radiography signs were chosen for necropsy and evaluation of the gross and histological changes of tissues. Blood and GI contents were collected for further analysis.

J o u r n a l P r e -p r o o f Target-2-P, 5'-FAM-TTGCTGCTGCTTGACAGATT-TAMRA-3'. The copy number of NP gene was calculated and expressed as log10 according to the standard curve of viral RNA to quantitate the genomic RNA of SARS-CoV-2 in the GI contents. For the GI tissues, the genomic RNA of SARS-CoV-2 was also determined via the NP gene, however the copy number was calculated via the comparative C t (∆∆Ct)method and normalized to the house keeping gene GAPDH, and then expressed as log10.

Vero E6 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum (FBS). Viral RNA-positive fecal specimens were used to make a PBS suspension, followed by filtration with a 0.22-µm syringe filter and dilution (1:10) with DMEM containing 2% J o u r n a l P r e -p r o o f FBS and antibiotics. Cells were infected at 37°C for 1 hour. The inoculum was removed and replaced with fresh culture medium. The cells were incubated at 37°C, and cytopathic effects were observed daily. If there was no obvious cytopathic effect until 6 dpi, the cells and supernatant were scraped up and freeze-thawed once prior to the second-round passage. The culture supernatant was analyzed for viral RNA by qRT-PCR and transmission electron microscopy.

Tissues of a proper size were fixed in 10% neutral-buffered formalin for 3-7 days.

Five-micrometer sections were prepared for hematoxylin and eosin (HE) staining and histopathological analysis. Areal density was used for analysis of CD68 and cleaved caspase 3 staining. Six images were randomly taken for analysis in one section of each animal. When taking photos, we tried to make the tissue fill the whole field of vision and ensured that the background of each photo is consistent. The brown yellow was used as the standard to define the positive staining via the Image Pro Plus 6.0 software. The integrated optical density (IOD) and the pixel area were measured in each photo. The areal density was calculated as IOD divided by pixel area.

The hybridization of viral RNA was performed on FFPE (Formalin-Fixed Paraffin-Embedded) sections according to the manufacturer's recommended procedures (RNAscope Multiplex Fluorescent v2 (Advanced Cell Diagnostics)) with some modifications. The probes were specific for analysis of the S gene of SARS-CoV-2 in NHPs (RNAscope® Probe-V-nCoV2019-S, ACD, Cat No. 848561, targeting the region of 21631 -23303 (NC_045512.2)). The stained sections were scanned and analyzed on a 3D HISTECH system.

FFPE sections were stained according to the manufacturer's recommended procedure for an AB-PAS staining kit (Cat No. G1285, Solarbio). The stained sections were scanned and analyzed on a 3D HISTECH system. Twenty crypts in one section of each animal were randomly selected for counting goblet cells in one crypt.

Cells infected with SARS-CoV-2 were scraped off culture dishes and harvested by centrifugation at 500 g for 5 min. The supernatant was removed without disrupting the pellet, followed by the gentle and slow addition of 2.5% glutaraldehyde without re-suspending the pellet. Fixation was performed at 4°C overnight. The next day, cells were embedded in epoxy resin,and ultrathin sections were made and stained with 2% uranium acetate and lead citrate. Slides were imaged under an electron microscope. 

A Student's t test was performed to compare differences between 2 groups. A P value <0.05 was considered statistically significant, and significant values are denoted as *. P<0.01 is denoted with **, P<0.005 with ***, and P<0.001 with ****. Figure 2D and 2E) . The results in the TCID50 assay suggested that viruses in tissues and GI contents are infectious (supplementary Figure 5A , 5B, 5D, 5E).

Together, these results suggested that intranasal inoculation of SARS-CoV-2 results in the pathological damages in both respiratory system and digestive system, and viruses were released from the infected tissues, which caused virus shedding.

Then, we hypothesized that GI inoculation with SARS-CoV-2 could result in infections in digestive tissues or even in respiratory tissues. To test this hypothesis, single-route intragastric inoculation with SARS-CoV-2 was performed to infect 5 rhesus monkeys, as shown in Figure   3A . One milliliter of 10 7 pfu SARS-CoV-2 was delivered directly into the stomach, followed by 

To examine the dynamics of SARS-CoV-2 after intragastric inoculation, we quantitated viral genomic RNA in samples from respiratory tissues, digestive tissues, GI contents, and blood. We had detected viral RNA in digestive tissues and their contents ( Figure 4A ), some pulmonary tissues (but not lung tissue), mesenteric lymph, and pancreatic and hepatic tissues ( Figure 4C ).

The TCID50 assay suggested that the majority of viruses detected in these tissues and J o u r n a l P r e -p r o o f gastroenteric contents were infectious (supplementary Figure 5C, 5D, 5E ). In situ hybridization confirmed the existence of viral RNA in some tissues ( Figure 4E ). Furthermore, viral RNA was also detectable in blood on 1, 4 and 7 dpi but not 14 dpi ( Figure 4B ). More importantly, viruses in the alimentary tract were discharged from the nose, throat and anus, which was evidenced by the presence of viral RNA in these swab samples ( Figure 4D ). In fact, we re-isolated viruses from one fecal sample of MM-O-7, which was confirmed by electronic microscopy ( Figure 4F) and TCID50 assay (=10 5 /ml). In vitro, the human epithelial cells Caco-2 is susceptible to SARS-CoV-2 (supplementary Figure 6 ). These results indicated that the fecal-oral route could be a potential transmission for SARS-CoV-2 infection.

To examine the host response to intragastric SARS-CoV-2 infection, inflammatory cytokines were analyzed in GI tissues. Compared with the uninfected animal, the 23 inflammatory cytokines assayed in each segment of the GI tract increased to varying degrees, especially in the middle and terminal segments of the digestive tract from SARS-CoV-2 infected animals ( Figure   5A ). On 14 dpi, some anti-inflammatory cytokines (G-CSF, IL-2, IL-10, IL-13 and MIP-1α) were induced and inflammatory cytokines (IFNγ, IL-1β) were inhibited. Next, we evaluated the expression of CD68, which is a marker for macrophages. Increased CD68 expression was observed in the duodenum, jejunum, ileum, and descending colon ( Figure 5B) , consistent with the expression of inflammatory cytokines ( Figure 5A ). To further investigate the immunopathological effects of these inflammatory responses, we necropsied five monkeys on 1, 4, 7 and 14 dpi, as outlined in Figure 4A . Histopathological analysis showed various degrees of pathological changes in the stomach, duodenum, jejunum, ileum, descending colon and rectum.

These pathological changes included the infiltration of inflammatory cells and loss of mucosal epithelium ( Figure 6A) , which was similar to the changes induced by intranasal inoculation ( Figure 1D ). The IHC staining of cleaved caspase 3 indicated that apoptosis was observed in the stomach, jejunum, descending colon and rectum on 1 dpi, and then was gradually mitigated 

and hACE2 transgenic mouse models, in which an increasing viral load was observed in stomachs, intestines, colons and rectums. [29] [30] [31] [32] [33] However, the infection route in these cases was either intratracheal, intranasal, a combination of multiple inoculations in animals or unclear in patients. Thus, these studies could not provide direct evidence of GI infection in vivo. Here, we characterized the GI infection of SARS-CoV-2 in rhesus monkeys after intranasal or intragastric J o u r n a l P r e -p r o o f inoculation. Clinically, respiratory symptoms may not be the initial presentations of SARS-CoV-2 patients. 5, 6 Respiratory infection was documented as a subsequent manifestation in some SARS-CoV-2 patients, whose initial symptoms were diarrhea and fever. 34 However, in this study, we still could not determine which system was firstly infected after intranasal administration of SARS-CoV-2. These viruses post intranasal inoculation traveled to the GI tissues, possibly via the lymphatic system or blood stream 35 and bound to the essential receptor ACE2. Though the two routes of SARS-CoV-2 inoculation in this study induced both pneumonia and GI tract dysfunction, there were at least two major differences between them. Intranasal inoculation with SARS-CoV-2 led to a higher viral load in respiratory and digestive tissues than intragastric inoculation. A possible explanation for this observation is that most SARS-CoV-2 that is intragastrically inoculated could be killed by gastric acid or other factors in the harsh GI environment. 9 Nevertheless, viruses protected by mucus or GI contents remained alive, and their replication led to infection, inflammation and pathological damage in the digestive system. In addition, inflammatory cytokines in serum, particularly sCD40L, TGFα, IL-15 and IL-1ra, were differentially induced by intranasal and intragastric inoculation with SARS-CoV-2 (supplementary Figure 4) . sCD40L, IL-15 and IL-1ra were induced by intranasal inoculation with SARS-CoV-2. TGFα was likely induced by intragastric inoculation. TGFα has been reported to inhibit the secretion of gastric acid. 36 It will be interesting to investigate whether intragastric inoculation with SARS-CoV-2 induces TGFα to allow viruses to escape from gastric acid. Therefore, the intranasal or intragastric inoculation with SARS-CoV-2 may lead to two distinct forms of pathogenesis.

Cytokine storms, but not the virus itself, are commonly recognized as a major pathogenic factor in SARS-CoV-2-induced pneumonia. 37 In this study, intragastric inoculation with SARS-CoV-2 led to pneumonia, but we could not assay viral RNA in the lung. SARS-CoV-2 that was intragastrically delivered to the digestive tract induced a large amount of inflammatory cytokines ( Figure 5A ) that overflowed to pulmonary tissues via the bloodstream or lymphatic system and caused inflammation, 38 which might further expel viruses from the lung. This may explain why viruses are sometimes not detectable in the lung.

The GI barrier, which consists of different types of IECs, plays important roles in preventing the entry of pathogens. The rapid turnover of IECs due to the vigorous proliferation of epithelial progenitors is thought to be an important defensive mechanism that works by expelling pathogens, confining bacterial spreading, and localizing inflammation. 39 The IHC staining of Ki67 and cleaved caspase 3 in this study indicated that SARS-COV-2 infection inhibited the cellular proliferation and induced apoptosis in the GI tract. Mucin secreted by goblet cells, the first defense layer, is important for preventing pathogen invasion. The absence of mucin makes the host more susceptible to pathogens. 40 Clinical studies and animal model of COVID-19 indicate that SARS-CoV-2 could be an enteric coronavirus 30, 33, [42] [43] 

A novel coronavirus outbreak of global health concern

A novel coronavirus from patients with pneumonia in China

Clinical characteristics of coronavirus disease 2019 in China

Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

First case of 2019 novel coronavirus in the United States

Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus

Crossing barriers: infections of the lung and the gut

Prolonged presence of SARS-CoV-2 viral RNA in faecal samples

Evidence for gastrointestinal infection of SARS-CoV-2

Detection of SARS-CoV-2 in different types of clinical specimens

Infection of bat and human intestinal organoids by SARS-CoV-2

SARS-CoV-2 viral load in upper respiratory specimens of infected patients

A pneumonia outbreak associated with a new coronavirus of probable bat origin

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein

SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells

Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids

SARS-CoV-2 productively infects human gut enterocytes

TMPRSS2 and TMPRSS4 mediate SARS-CoV-2 infection of human small intestinal enterocytes

Airborne spread of SARS-CoV-2 and a potential role for air disinfection

Current knowledge and research priorities in the digestive manifestations of COVID-19

Multiomics evaluation of gastrointestinal and other clinical characteristics of COVID-19

Meta-analysis of outcomes of patients with COVID-19 infection with versus without gastrointestinal symptoms

Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms

Reinfection could not occur in SARS-CoV-2 infected rhesus macaques

Respiratory disease in rhesus macaques inoculated with SARS-CoV-2

Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model

The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

A mouse model of SARS-CoV-2 infection and pathogenesis

Digestive symptoms in COVID-19 patients with mild disease severity: clinical presentation, stool viral RNA testing, and outcomes

Pathogenesis: infection and the spread of viruses in the body

Transforming growth factor alpha inhibits secretion of gastric acid

The pathogenesis and treatment of the `Cytokine Storm' in COVID-19

Lung inflammation originating in the gut

Intrinsic defense mechanisms of the intestinal epithelium

The mucin Muc2 limits pathogen burdens and epithelial barrier dysfunction during Salmonella enterica serovar Typhimurium colitis

Is SARS-CoV-2 Also an Enteric Pathogen With Potential Fecal-Oral Transmission? A COVID-19 Virological and Clinical Review

SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and prolonged shedding of infectious virus from both respiratory and gastrointestinal tracts

Comparison of nonhuman primates identified the suitable model for COVID-19

Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus

Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection

Presence and vitality of SARS-CoV-2 virus in wastewaters and rivers

SARS-CoV-2 RNA in wastewater anticipated COVID-19 occurrence in a low prevalence area

First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: A proof of concept for the wastewater surveillance of COVID-19 in the community

Presence of SARS-Coronavirus-2 RNA in Sewage and Correlation with Reported COVID-19 Prevalence in the Early Stage of the Epidemic in The Netherlands

SARS-CoV-2 RNA concentrations in primary municipal sewage sludge as a leading indicator of COVID-19 outbreak dynamics

SARS-CoV-2 titers in wastewater foreshadow dynamics and clinical presentation of new COVID-19 cases

Evaluation of lockdown impact on SARS-CoV-2 dynamics through viral genome quantification in Paris wastewaters

Detection of SARS-Coronavirus-2 in wastewater, using the existing environmental surveillance network: An epidemiological gateway to an early warning for COVID-19 in communities

Sewer surveillance part of Dutch national Covid-19 dashboard

Sewage could hold the key to stopping new coronavirus outbreaks" 1

Historical context and initial expectations on sewage surveillance to inform the control of COVID-19. HealthStream, Water Research Australia

Representative images from one intranasally inoculated animal are shown here. (C) This plot shows the quantitative analysis of macrophages in the panel (B)

001). (D) Viral loads in the digestive tract contents were determined by qRT-PCR after intranasal inoculation. (E) Virus shedding was monitored by qRT-PCR every day after intranasal inoculation

At the same time, blood and fecal samples were collected for further analysis. The animals (MM-O-1, MM-O-4, MM-O-7, MM-O-14-1/2) was necropsied on 1, 4, 7 and 14 dpi, respectively. (B) Pulmonary changes post infection. Left: chest radiographs (red circles indicate areas of nodular lesions caused by pulmonary infiltrates)

One representative animal (MM-O-14-1) on 14 dpi was shown here since two animals had similarly mitigatory manifestations. (C) Twenty-three inflammatory cytokines were analyzed in lung tissue lysates after intragastric challenge with SARS-CoV-2. The highest level of cytokine as 1 is used to normalize other samples within one column

Dynamic analysis of viruses in rhesus monkeys after intragastric inoculation with SARS-CoV-2. (A) Viral genomic RNA was detected with qRT-PCR in digestive tissues (top panel) and their contents (bottom panel) from several parts of the alimentary tract and blood (B) compared with the control MM-O/N-0

Author names in bold designate shared co-first authorship.J o u r n a l P r e -p r o o f